RAYNHAM, Mass., Aug. 8, 2018 /PRNewswire/ — OMNIlife science, Inc. (“OMNI”), a privately-held, established medical technology company targeting the $15 billion global hip and knee replacement device market, announced today that Brigham Redd, M.D., of Liljenquist & Redd Orthopedic Surgery, is the first surgeon in Idaho to offer OMNIBotics, an advanced robotic-assisted treatment option for total knee replacement. This innovative total knee replacement […]